Earnings Review
Sharp growth in expenses dents Coromandel Intl Q3 PAT
This story was originally published at 16:49 IST on 29 January 2026
Register to read our real-time news.Informist, Thursday, Jan. 29, 2026
Please click here to read all liners published on this story
--Coromandel Intl Oct-Dec consol net profit INR 5.06 bln
--Coromandel Intl Oct-Dec consol revenue INR 87.79 bln
--Coromandel Intl Oct-Dec consol PAT INR 4.88 bln vs INR 5.10 bln year ago
--Coromandel Intl Oct-Dec consol revenue INR 87.79 bln vs INR 69.35 bln
--Coromandel Intl to pay INR 9 per share interim dividend
--Coromandel Intl interim dividend record date is Feb 4
--Coromandel Intl Apr-Dec consol PAT INR 17.84 bln vs INR 14.76 bln year ago
--Coromandel Intl Apr-Dec consol revenue INR 254.76 bln vs INR 190.97 bln
--Coromandel Intl shares at INR 2,230.40, down 1.2% vs up nearly 1% earlier
--Coromandel Intl shrs fall; Q3 consol PAT down on year
By Adhithya Aji
MUMBAI – A sharp growth in expenses dented Coromandel International Ltd.'s consolidated net profit for the December quarter despite a double-digit growth in sales. The company posted double-digit on year growth in top line for the fifth consecutive quarter.
The organic fertiliser manufacturer reported a consolidated net profit of INR 5.06 billion, down over 1% from INR 5.12 billion reported in the year-ago quarter. The company's revenue rose nearly 27% on year to INR 87.79 billion in the December quarter. Sequentially, the net profit fell by over 37% and sales declined by over 9%.
Coromandel International reported its December quarter results during market hours. Its shares fell by more than 3% from the day's high after the results. Thursday, the company's shares ended 0.3% lower at INR 2,249.50 on the National Stock Exchange.
The company's total income rose nearly 26% to INR 88.63 billion in the December quarter. Other income was INR 832 million, down nearly 27% from INR 1.14 billion in the year-ago quarter. The total expenditure rose by over 29% to INR 82.10 billion. Within this, raw material costs, which accounted for over 58% of total expenses, rose nearly 43% to INR 47.95 billion. Purchases of traded goods rose over 37% to INR 28.86 billion from INR 21.03 billion in the year-ago quarter. Other expenses rose 47% on year to INR 4.98 billion.
The nutrients and allied business segment reported a consolidated sales of INR 77.62 billion, up nearly 22% on year. The crop protection segment's consolidated sales were INR 10.98 billion, up nearly 73% on year.
The board of the company approved an interim dividend of INR 9 per equity share, with the record date set for Wednesday.
For Apr-Dec, the company reported consolidated net profit of INR 17.84 billion, up nearly 21% year over year. The company's revenue rose over 33% to INR 254.76 billion for the same period. End
Edited by Saji George Titus
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2026. All rights reserved.
To read more please subscribe
Share this Story:
